These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 9293535

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Nucleolar organizer regions in hepatocellular carcinoma related to the cell cycle, cell proliferation and histologic grade.
    Nagao T, Ishida Y, Yamazaki K, Kondo Y.
    Pathol Res Pract; 1995 Oct; 191(10):967-72. PubMed ID: 8838363
    [Abstract] [Full Text] [Related]

  • 3. The nucleolar organizer regions in hyperplastic and tumorous lesions of the human liver.
    Zalatnai A, Lapis K, Fehér I.
    Pathol Res Pract; 1993 Jun; 189(5):536-41. PubMed ID: 8397389
    [Abstract] [Full Text] [Related]

  • 4. Hyperplastic foci in chronic liver disease: their proliferative activity assessed by nucleolar organizing region.
    Wakasa K, Haba T, Sasaki M, Sakurai M, Ikebe T, Shuto T, Hirohashi K, Kinoshita H.
    Pathol Int; 1998 Jan; 48(1):29-32. PubMed ID: 9589461
    [Abstract] [Full Text] [Related]

  • 5. Assessment of nucleolar organizer regions (NORs) in proliferative conditions of the liver.
    Siddiqui MS, Soomro IN, Kayani N, Muzaffar S, Hasan SH.
    Pathol Res Pract; 1999 Jan; 195(6):421-6. PubMed ID: 10399183
    [Abstract] [Full Text] [Related]

  • 6. Argyrophilic nucleolar organizer regions and alpha-fetoprotein in adenomatous hyperplasia in human cirrhotic livers.
    Terasaki S, Terada T, Nakanuma Y, Nonomura A, Unoura M, Kobayashi K.
    Am J Clin Pathol; 1991 Jun; 95(6):850-7. PubMed ID: 1710418
    [Abstract] [Full Text] [Related]

  • 7. Hepatocyte proliferation rate is a powerful parameter for predicting hepatocellular carcinoma development in liver cirrhosis.
    Borzio M, Trerè D, Borzio F, Ferrari AR, Bruno S, Roncalli M, Colloredo G, Leandro G, Oliveri F, Derenzini M.
    Mol Pathol; 1998 Apr; 51(2):96-101. PubMed ID: 9713593
    [Abstract] [Full Text] [Related]

  • 8. AgNOR counts are not altered in alcoholic cirrhosis.
    Misra V, Misra SP, Dwivedi M, Gupta SC.
    Indian J Pathol Microbiol; 2003 Apr; 46(2):170-2. PubMed ID: 15022901
    [Abstract] [Full Text] [Related]

  • 9. Incidence of adenomatous hyperplasia in postmortem cirrhotic livers and study of cellular proliferative indices by light microscopy.
    Vaiphei K, Ghosh UK, Vasishta RK.
    Indian J Gastroenterol; 1999 Apr; 18(1):7-10. PubMed ID: 10063738
    [Abstract] [Full Text] [Related]

  • 10. Enzymatic cytochemistry, DNA ploidy and AgNOR quantitation in hepatocellular nodules of uncertain malignant potential in liver cirrhosis.
    Bolondi L, Gramantieri L, Chieco P, Melchiorri C, Treré D, Stecca B, Derenzini M, Barbara L.
    Dig Dis Sci; 1996 Apr; 41(4):800-8. PubMed ID: 8674404
    [Abstract] [Full Text] [Related]

  • 11. AgNORs in ductal breast cancer: correlation with ploidy and S-phase fraction by DNA flow cytometry.
    Borgiani L, Cogorno P, Oliviero J, Toso F, Gambini G, Tunesi G, Canepa M.
    Eur J Histochem; 1994 Apr; 38(2):171-6. PubMed ID: 7524814
    [Abstract] [Full Text] [Related]

  • 12. A clinicopathologic study of adenomatous hyperplasia of the liver in 209 consecutive cirrhotic livers examined by autopsy.
    Terada T, Terasaki S, Nakanuma Y.
    Cancer; 1993 Sep 01; 72(5):1551-6. PubMed ID: 8394196
    [Abstract] [Full Text] [Related]

  • 13. [Evaluation of the biological malignancy in hepatocellular carcinoma by argyrophilic nucleolar organizer region (AgNOR) staining--morphological study of AgNOR using image analyzer].
    Shiro T, Seki T, Naitoh Y, Nakagawa T, Wakabayashi M, Itoh T, Shiozaki Y, Inoue K, Okamura A.
    Nihon Shokakibyo Gakkai Zasshi; 1994 Mar 01; 91(3):267-78. PubMed ID: 7908344
    [Abstract] [Full Text] [Related]

  • 14. Silver-stained nucleolar organizer regions in normal and dysplastic cervical lesions: correlation with DNA ploidy and S-phase fraction by flow cytometry.
    Singh M, Prasad S, Kalra N, Singh U, Shukla Y.
    Oncology; 2006 Mar 01; 71(5-6):411-6. PubMed ID: 17785995
    [Abstract] [Full Text] [Related]

  • 15. Hepatocellular carcinoma and preneoplastic lesions of the liver: evaluation of argyrophilic nucleolar organizer regions (AgNORs).
    Bufo P, Frassanito F.
    Boll Soc Ital Biol Sper; 1992 Nov 01; 68(11):707-14. PubMed ID: 1338418
    [Abstract] [Full Text] [Related]

  • 16. Nucleolar organizer regions in cirrhosis and hepatocellular carcinoma.
    Jain R, Malhotra V, Kumar N, Sarin SK.
    Trop Gastroenterol; 1998 Nov 01; 19(3):100-1. PubMed ID: 9828706
    [Abstract] [Full Text] [Related]

  • 17. A correlation of argyrophilic nucleolar organizer regions with stages of hepatocellular carcinoma.
    Shiro T, Seki T, Naitoh Y, Inoue K, Okamura A.
    Cancer; 1993 Jan 01; 71(1):44-9. PubMed ID: 8380120
    [Abstract] [Full Text] [Related]

  • 18. Nucleolar organizer regions (NORs) in normal and pathological liver: a quantitative analysis.
    Anselmi L, Sementa AR, Borgiani L, Banderali A, Rovida S.
    Pathologica; 1990 Jan 01; 82(1082):653-62. PubMed ID: 1965612
    [Abstract] [Full Text] [Related]

  • 19. Nucleolar organiser regions in normal, cirrhotic, and carcinomatous livers.
    Crocker J, McGovern J.
    J Clin Pathol; 1988 Oct 01; 41(10):1044-8. PubMed ID: 2848058
    [Abstract] [Full Text] [Related]

  • 20. Hyperplastic foci reflect the risk of multicentric development of human hepatocellular carcinoma.
    Sugitani S, Sakamoto M, Ichida T, Genda T, Asakura H, Hirohashi S.
    J Hepatol; 1998 Jun 01; 28(6):1045-53. PubMed ID: 9672182
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.